Stable pharmaceutical formulation
- 专利权人:
- Oryzon Genomics; S.A.
- 发明人:
- MAURER, Reto,BUSSON, Patrick,HUMMEL, Georg
- 申请号:
- AU2019264231
- 公开号:
- AU2019264231A1
- 申请日:
- 2019.05.06
- 申请国别(地区):
- AU
- 年份:
- 2020
- 代理人:
- 摘要:
- The present invention relates to a pharmaceutical composition of (trans)-N 1 -((1 R,2S)-2- phenylcyclopropyl)cyclohexane- 1,4-diamine, a process for the preparation thereof and its use in the treatment of diseases.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- AMORPHOUS FORM OF VILAZODONE HYDROCHLORIDE AND PROCESS FOR PREPARING THEREOF
- CRYSTALLINE FORMS OF SODIUM 4-{[9-CHLORO-7-(2-FLUORO-6-METHOXYPHENYL)-5H -PYRIMIDO[5,4-D][2]BENZAZEPIN-2YL]AMINO}-2-METHOXYBENZOATE
- Solid state forms of racemic ilaprazole
- PHARMACEUTICAL SOLID DOSAGE FORM FOR ORAL ADMINISTRATION AND METHOD FOR PREPARING THE SAME.
- COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING DISEASES CONDITION OR PROCESSES CHARACTERIZED BY ABERRANT PROLIFERATION OF FIBROBLASTS AND DEPOSITION OF THE EXTRACELLULAR MATRIX